A detailed history of Bank Of America Corp transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 2,104,724 shares of SGHT stock, worth $7.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,104,724
Previous 3,147,831 33.14%
Holding current value
$7.51 Million
Previous $21 Million 36.85%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.49 - $8.31 $5.73 Million - $8.67 Million
-1,043,107 Reduced 33.14%
2,104,724 $13.3 Million
Q2 2024

Aug 14, 2024

SELL
$5.13 - $7.15 $74,754 - $104,189
-14,572 Reduced 0.46%
3,147,831 $21 Million
Q1 2024

May 15, 2024

SELL
$4.02 - $5.89 $47,158 - $69,095
-11,731 Reduced 0.37%
3,162,403 $16.7 Million
Q4 2023

Feb 14, 2024

BUY
$1.29 - $5.86 $3.99 Million - $18.1 Million
3,093,562 Added 3839.5%
3,174,134 $16.4 Million
Q2 2023

Aug 14, 2023

SELL
$7.46 - $10.67 $175,101 - $250,446
-23,472 Reduced 22.56%
80,572 $667,000
Q1 2023

May 12, 2023

BUY
$8.44 - $13.35 $27,244 - $43,093
3,228 Added 3.2%
104,044 $909,000
Q4 2022

Feb 10, 2023

BUY
$5.58 - $13.94 $126,493 - $316,005
22,669 Added 29.01%
100,816 $1.23 Million
Q3 2022

Nov 14, 2022

SELL
$6.1 - $11.41 $9,400 - $17,582
-1,541 Reduced 1.93%
78,147 $496,000
Q2 2022

Aug 12, 2022

BUY
$6.61 - $11.99 $342,021 - $620,398
51,743 Added 185.16%
79,688 $716,000
Q1 2022

May 16, 2022

BUY
$11.56 - $17.9 $224,587 - $347,761
19,428 Added 228.11%
27,945 $324,000
Q4 2021

Feb 08, 2022

SELL
$17.36 - $27.36 $128,932 - $203,202
-7,427 Reduced 46.58%
8,517 $149,000
Q3 2021

Nov 15, 2021

BUY
$22.34 - $39.1 $356,188 - $623,410
15,944 New
15,944 $361,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $171M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.